GSE137542
Leukemias from NP23-NHD13 double transgenic mice - WES study
Whole exome sequencing (the SureSelectXT Mouse All Exon Kit) was done on leukemias from NP23-NHD13 double transgenic mice with strain background designated “C57Bl6-NIH”. Overall design: 17 NP23-NHD13 thymic AML mice compared with the WT mice.